Shanghai ZJ Bio-Tech Co. LtdSSE: 688317

(688317)"Shanghai ZJ Bio-Tech Co., Ltd."Announcement on Third Repurchase of Shares through Call Auction in 2025 Reaching 3% of Total Share Capital and Results of Share Repurchase

· Issued by Shanghai ZJ Bio-Tech Co. Ltd via Shanghai Stock Exchange

Filed with SSE · Stock code 688317 · · 4 pages · Chinese

Summary by 6ix AI

Shanghai ZJ Bio-Tech Co. Ltd announced the results of its third share repurchase through call auction, reaching a significant portion of its total share capital. The company repurchased shares amounting to a specific percentage of its total capital, with details on the implementation and approval of the repurchase plan provided. The repurchase was conducted using self-funds and a bank loan, ensuring it does not impact the company's operations or financial status significantly.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/688317shanghai-zj-bio-tech-co-ltdannouncement-on-third-repurchase-of-shares-through-call-auction-in-2025-reaching-3percent-of-total-share-capital-and-results-of-share-repurchase

Release

Announcement on Third Repurchase of Shares through Call Auction in 2025 Reaching 3% of Total Share Capital and Results of Share Repurchase

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Shanghai ZJ Bio-Tech Co. Ltd on 6ix

Story so far

Earlier from Shanghai ZJ Bio-Tech

All Shanghai ZJ Bio-Tech news releases